Influence of treatment and response status on infection risk in multiple myeloma

The American Journal of Medicine

Volumn 71, Issue 6, 1981, Pages 935-940

  Perri, Robert T ^a   Hebbel, Robert P ^a   Oken, Martin M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CYCLOPHOSPHAMIDE; CYTOSTATIC AGENT; MELPHALAN; PREDNISONE;

ADVERSE DRUG REACTION; BACTERIAL INFECTION; CANCER CHEMOTHERAPY; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; ORAL DRUG ADMINISTRATION; THERAPY;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CREATININE; DRUG THERAPY, COMBINATION; FEMALE; HUMAN; IMMUNOGLOBULINS; INFECTION; MALE; MIDDLE AGE; MULTIPLE MYELOMA; PROGNOSIS; RISK;

EID: 0019825038     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(81)90303-X     Document Type: Article

References (25)

1. Infections complicating multiple myeloma and chronic lymphocytic leukemia
2. Current patterns of infections in patients with multiple myeloma (abstr)
3. Infection, antibody response and gamma globulin components in multiple myeloma and macroglobulinemia
4. Recurrent pneumonia in multiple myeloma and some observations on immunologic response
5. A review of fifty-one cases of myeloma emphasis on pneumonia and other infections as complications
6. Current patterns of infection in multiple myeloma
7. Managing the complications of plasma cell myeloma
8. Infections in patients with multiple myeloma
9. Proposed guidelines for protocol studies. II. Plasma cell myeloma
10. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival
11. Localized indolent myeloma
12. Smoldering multiple myeloma
13. Combination chemotherapy for multiple myeloma
14. BCNU, cyclophosphamide, prednisone vs. melphalan-prednisone in multiple myeloma (abstr)
15. Combination chemotherapy with intermittent 1-3-bis (2-chloroethyl) 1-nitrosourea (BCNU), cyclophosphamide and prednisone for multiple myeloma
16. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
17. The chemotherapy of plasma-cell myeloma and the incidence of acute leukemia
18. Multiple myeloma. Review of 869 cases
19. Clinical patterns of the plasma cell dyscrasias
20. Role of gamma globulin for immunoprophylaxis in multiple myeloma
21. Pneumococcal vaccination the response of patients with multiple myeloma
22. A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocytopenic patients
23. A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia